Data collection of results from analyses on drug samples from drug checking services in Europe.

The European Union Drugs Agency (EUDA) has announced a tender titled "Data collection of results from analyses on drug samples from drug checking services in Europe," identified by the reference EUDA2025OP0008. This tender seeks to integrate data collected from drug checking services across Europe into the EUDA’s data framework with the objective of enhancing real-time monitoring, early detection of emerging threats, and risk communication regarding psychoactive substances. The contract has an estimated total value of €300,000 and spans a maximum duration of 36 months. It is classified under the Common Procurement Vocabulary (CPV) code 73200000, indicating research and development consultancy services. The contract will be awarded based on the best price-quality ratio, and there is no mention of a framework agreement. Participants must submit their tenders electronically by the deadline of September 17, 2025, at 17:00 Europe/Lisbon time, with a public opening scheduled for September 18, 2025, at 10:30 Europe/Lisbon time. Questions regarding the tender must be submitted by September 9, 2025, and the agency is not obligated to respond to inquiries received after this date. Eligible applicants include a variety of organizations capable of providing the requisite services. This may encompass research institutions, consulting firms, and other entities experienced in data collection and analysis related to drug checking services. While there is allowance for participation in consortia, the tender also permits single submissions. The project’s geographical focus is Europe, particularly targeting EU member states. The undertaking is operational in nature, concerning the collection and integration of existing data, rather than initiating a new service framework. Interested parties must obtain a Personal Identification Code (PIC) to participate in the tender process. Key documents for submission include administrative and technical specifications, as well as various templates related to declarations of honor and agreements with subcontractors if applicable. In summary, this tender represents an opportunity for firms to engage in a significant project aimed at advancing public health monitoring and addressing drug-related issues across Europe through effective data management and analysis.

The European Union Drugs Agency (EUDA) has issued an invitation to tender, EUDA2025OP0008, for a project focused on drug checking. The tender, titled "Data collection of results from analyses on drug samples from drug checking services in Europe," was published on July 25, 2025, with version 1 currently available only in English. No translations are available.

The primary objective of this contract is to integrate analytical data from drug checking services across Europe into the EUDA’s data collection framework. This integration aims to enhance the agency's capacity for real-time monitoring, early detection, and risk communication related to emerging psychoactive substances and drug-related threats.

The EUDA, a new agency with a broadened mandate, is designed to strengthen the EU’s preparedness in addressing current and future drug problems. The agency will support the EU and its Member States by providing services in four key categories: anticipating new challenges, alerting on emerging risks, assessing needs and responses, and evaluating and disseminating new knowledge and best practices.

This call for tenders follows an open procedure. The estimated total value of the contract is €300,000. The TED (Tenders Electronic Daily) reference for this tender is 141/2025 486913-2025. The main classification according to the Common Procurement Vocabulary (CPV) is 73200000, which pertains to research and development consultancy services. The nature of the contract is for services, with a maximum contract duration of 36 months. The award method will be based on the best price-quality ratio. No framework agreement is specified.

Key milestones for this tender include:

TED publication date:July 25, 2025

Date and time of public opening:September 18, 2025, at 10:30 Europe/Lisbon time

Deadline for receipt of tenders:September 17, 2025, at 17:00 Europe/Lisbon time

Deadline for submitting questions:September 9, 2025, at 06:00 Europe/Lisbon time. The contracting authority is not bound to reply to questions submitted after this date.

Submissions must be sent exclusively via electronic means through the designated submission address.

The following documents are available for download:

Invitation to tender EUDA2025OP0008 Drug Checking Invitation letter

Tender specifications EUDA-2025-OP-0008 Part 1 Administrative specifications

Tender specifications EUDA-2025-OP-0008 Part 2 Technical specifications

Annex 1 Tenderer's check-list

Annex 2 Declaration-of-honour-tenders EUDA2025OP0008

Annex 3 Agreement/Power of attorney

Annex 4 List of identified subcontractors

5.1 Commitment letter by an identified subcontractor

Annex 5.2 Commitment letter by an entity on whose capacities is being relied

Annex 6 Draft contract

The eSubmission system supports the latest versions of Google Chrome and Mozilla Firefox. The system is multilingual, supporting all 24 official EU languages, and uses UTF-8 character set encoding. It encrypts all uploaded documents using an asymmetric key to ensure integrity and confidentiality. The maximum file size for attachments is 50 MB, and the maximum number of documents that can be uploaded per tender is 200.

A Personal Identification Code (PIC) is mandatory for participation as a sole candidate or as part of a consortium.

This tender is about collecting and integrating drug analysis data from various drug checking services across Europe into a centralized EU database managed by the EUDA. The goal is to improve the EU's ability to monitor drug trends, detect emerging threats, and communicate risks associated with psychoactive substances more effectively. The EUDA aims to support EU member states in addressing drug-related issues by anticipating challenges, alerting to risks, assessing responses, and sharing knowledge. Organizations with expertise in data collection, analysis of drug samples, and integration of data into existing frameworks are encouraged to apply. The tender involves providing services related to research and development consultancy, with a focus on enhancing the EU's drug monitoring and risk communication capabilities.

Eligible Applicant Types:The eligible applicant types are not explicitly stated in the provided text. However, given that it is a call for tenders, it is likely open to organizations capable of providing the required services. This could include research institutions, consulting firms, or other entities with expertise in data collection and analysis related to drug checking services. The requirement for a PIC (Personal Identification Code) suggests that any legal entity can apply, potentially including SMEs, large enterprises, research institutions, and possibly NGOs.

Funding Type:The funding type is procurement, specifically a service contract. The call is for "Data collection of results from analyses on drug samples from drug checking services in Europe," indicating a service to be provided in exchange for payment.

Consortium Requirement:The text mentions the possibility of participating "as a member of a group (consortium)," indicating that consortia are allowed. It also mentions subcontractors, further suggesting that multiple entities can be involved in a single tender. Therefore, either a single applicant or a consortium is acceptable.

Beneficiary Scope (Geographic Eligibility):The description specifies "drug checking services across Europe," implying that the geographic eligibility is Europe. Given that the European Union Drugs Agency (EUDA) is the lead contracting authority, it is highly likely that the eligibility is focused on EU member states, but could potentially include EEA countries or other countries with established drug checking services in Europe.

Target Sector:The target sector is health and security, specifically related to drug policy, drug monitoring, and public health. It also touches on research and development consultancy services. The specific area is data collection and analysis related to drug samples and emerging psychoactive substances.

Mentioned Countries:The opportunity mentions "Europe" as the region where the drug checking services are located. It also mentions "EU Member States" in the context of the EUDA's support.

Project Stage:The project stage is operational. The call is for data collection services, implying that the infrastructure for drug checking is already in place and the focus is on gathering and integrating the data.

Funding Amount:The estimated total value of the contract is €300,000.

Application Type:The application type is an open call for tenders, with electronic submission.

Nature of Support:The beneficiaries will receive money in exchange for services rendered. This is a service contract, so payment is for the provision of data collection and analysis services.

Application Stages:The number of application stages is not explicitly mentioned, but based on the documentation provided (invitation letter, administrative specifications, technical specifications, annexes, draft contract), it is likely a multi-stage process involving submission of a tender, evaluation, and contract award. A minimum of 2 stages can be inferred: submission and evaluation.

Success Rates:The success rates are not mentioned in the provided text.

Co-funding Requirement:The co-funding requirement is not explicitly mentioned. Given that it is a procurement contract, co-funding is unlikely, but this should be confirmed in the tender specifications.

Summary:This is a call for tenders by the European Union Drugs Agency (EUDA) for the "Data collection of results from analyses on drug samples from drug checking services in Europe." The EUDA aims to integrate analytical data from drug checking services across Europe into its data collection framework to enhance real-time monitoring, early detection, and risk communication regarding emerging psychoactive substances and drug-related threats. The procedure is an open call for tenders, with electronic submission required. The estimated total value of the contract is €300,000, and the maximum contract duration is 36 months. The call is open to any organization capable of providing the required services, potentially including research institutions, consulting firms, and other entities with expertise in data collection and analysis. A Personal Identification Code (PIC) is mandatory for participation. The deadline for receipt of tenders is 17/09/2025 at 17:00 Europe/Lisbon. The award method is based on the best price-quality ratio. Tenderers must submit their proposals electronically, adhering to the system requirements specified in the documentation. The EUDA will use the collected data to support the EU and its Member States in addressing the drug situation by anticipating new challenges, alerting on emerging risks, assessing needs, and evaluating new knowledge and best practices.